Esser Katherine, Butler James J, Roof Mackenzie, Mercer Nathaniel P, Harrington Michael C, Samsonov Alan P, Rosenbaum Andrew J, Kennedy John G
Department of Orthopaedic Surgery University of Toledo Medical Center, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, United States.
Department of Orthopedic Surgery, NYU Langone Health, New York, NY 10002, United States.
World J Orthop. 2024 Jun 18;15(6):585-592. doi: 10.5312/wjo.v15.i6.585.
Cheilectomy of the 1 metatarsophalangeal joint (MTPJ) is one of the most common procedures for the management of hallux rigidus. However, there is no consensus regarding outcomes following minimally invasive dorsal cheilectomy (MIDC) for the management of hallux rigidus.
To evaluate outcomes following MIDC for the management of hallux rigidus.
During November 2023, the PubMed, EMBASE and Cochrane Library databases were systematically reviewed to identify clinical studies examining outcomes following MIDC for the management of hallux rigidus.
Six studies were included. In total, 348 patients (370 feet) underwent MIDC for hallux rigidus at a weighted mean follow-up of 37.9 ± 16.5 months. The distribution of patients by Coughlin and Shurna's classification was recorded in 4 studies as follows: I (58 patients, 27.1%), II (112 patients, 52.3%), III (44 patients, 20.6%). Three studies performed an additional 1 MTPJ arthroscopy and debridement following MIDC. Retained intra-articular bone debris was observed in 100% of patients in 1 study. The weighted mean American orthopedic foot and ankle society score improved from a preoperative score of 68.9 ± 3.2 to a postoperative score of 87.1. The complication rate was 8.4%, the most common of which was persistent joint pain and stiffness. Thirty-two failures (8.7%) were observed. Thirty-three secondary procedures (8.9%) were performed at a weighted mean time of 8.6 ± 3.2 months following the index procedure.
This systematic review demonstrated improvements in subjective clinical outcomes together with a moderate complication rate following MIDC for the management of hallux rigidus at short-term follow-up. A moderate re-operation rate at short-term follow-up was recorded. The marked heterogeneity between included studies and paucity of high quality comparative studies limits the generation of any robust conclusions.
第一跖趾关节(MTPJ)切除术是治疗僵硬性拇趾的最常见手术之一。然而,对于微创背侧跖趾关节切除术(MIDC)治疗僵硬性拇趾后的疗效尚无共识。
评估MIDC治疗僵硬性拇趾后的疗效。
2023年11月,对PubMed、EMBASE和Cochrane图书馆数据库进行系统回顾,以确定研究MIDC治疗僵硬性拇趾后疗效的临床研究。
纳入6项研究。共有348例患者(370足)接受了MIDC治疗僵硬性拇趾,加权平均随访时间为37.9±16.5个月。4项研究记录了根据考夫林和舒尔纳分类法的患者分布情况如下:I型(58例患者,27.1%),II型(112例患者,52.3%),III型(44例患者,20.6%)。3项研究在MIDC后额外进行了1次MTPJ关节镜检查和清创术。1项研究中100%的患者观察到关节内残留骨碎片。美国矫形足踝协会评分加权平均值从术前的68.9±3.2提高到术后的87.1。并发症发生率为8.4%,最常见的是持续性关节疼痛和僵硬。观察到32例失败病例(8.7%)。在初次手术加权平均时间8.6±3.2个月后进行了33次二次手术(8.9%)。
本系统评价表明,在短期随访中,MIDC治疗僵硬性拇趾后主观临床疗效有所改善,并发症发生率中等。短期随访中记录到中等的再次手术率。纳入研究之间存在明显异质性,高质量比较研究匮乏,限制了得出任何有力结论。